Dirk K F Meijer - JoVE Visualize

Showing results (41-50 of 55) with videos related to

Pageof 6

Sort By:

International Journal of Cancer|November 15, 2002

Targeting of RGD-modified proteins to tumor vasculature: a pharmacokinetic and cellular distribution studyAstrid J Schraa, Robbert J Kok, Henk E Moorlag, et al.

Journal of the American Society of Nephrology : JASN|July 25, 2008

Inhibition of renal rho kinase attenuates ischemia/reperfusion-induced injuryJai Prakash, Martin H de Borst, Marie Lacombe, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|October 5, 2002

Endothelial cells internalize and degrade RGD-modified proteins developed for tumor vasculature targetingAstrid J Schraa, Robbert J Kok, Agnes D Berendsen, et al.

Biochimica Et Biophysica Acta|May 12, 2007

A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated ratsJoanna E Adrian, Jan A A M Kamps, Gerrit L Scherphof, et al.

Antiviral Therapy|May 17, 2007

A phase I/IIa study with succinylated human serum albumin (Suc-HSA), a candidate HIV-1 fusion inhibitorJoost N Vermeulen, Dirk K F Meijer, Jan Over, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|February 10, 2006

Selective targeting of pentoxifylline to hepatic stellate cells using a novel platinum-based linker technologyTeresa Gonzalo, Eduard G Talman, Anke van de Ven, et al.

Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2002

Selective intracellular delivery of dexamethasone into activated endothelial cells using an E-selectin-directed immunoconjugateMaaike Everts, Robbert J Kok, Sigridur A Asgeirsdóttir, et al.

Pharmaceutical Research|January 10, 2008

Cell-specific delivery of a transforming growth factor-beta type I receptor kinase inhibitor to proximal tubular cells for the treatment of renal fibrosisJai Prakash, Martin H de Borst, Annemiek M van Loenen-Weemaes, et al.

Molecular Pharmacology|December 16, 2004

Optimized targeting of polyethylene glycol-stabilized anti-intercellular adhesion molecule 1 oligonucleotide/lipid particles to liver sinusoidal endothelial cellsMartin Bartsch, Alida H Weeke-Klimp, Henriëtte W M Morselt, et al.

Toxicological Sciences : an Official Journal of the Society of Toxicology|February 25, 2005

Precision-cut liver slices as a new model to study toxicity-induced hepatic stellate cell activation in a physiologic milieuMarja van de Bovenkamp, Geny M M Groothuis, Annelies L Draaisma, et al.

Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:

Pageof 6

International Journal of Cancer|November 15, 2002

Targeting of RGD-modified proteins to tumor vasculature: a pharmacokinetic and cellular distribution studyAstrid J Schraa, Robbert J Kok, Henk E Moorlag, et al.

Journal of the American Society of Nephrology : JASN|July 25, 2008

Inhibition of renal rho kinase attenuates ischemia/reperfusion-induced injuryJai Prakash, Martin H de Borst, Marie Lacombe, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|October 5, 2002

Endothelial cells internalize and degrade RGD-modified proteins developed for tumor vasculature targetingAstrid J Schraa, Robbert J Kok, Agnes D Berendsen, et al.

Biochimica Et Biophysica Acta|May 12, 2007

A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated ratsJoanna E Adrian, Jan A A M Kamps, Gerrit L Scherphof, et al.

Antiviral Therapy|May 17, 2007

A phase I/IIa study with succinylated human serum albumin (Suc-HSA), a candidate HIV-1 fusion inhibitorJoost N Vermeulen, Dirk K F Meijer, Jan Over, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|February 10, 2006

Selective targeting of pentoxifylline to hepatic stellate cells using a novel platinum-based linker technologyTeresa Gonzalo, Eduard G Talman, Anke van de Ven, et al.

Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2002

Selective intracellular delivery of dexamethasone into activated endothelial cells using an E-selectin-directed immunoconjugateMaaike Everts, Robbert J Kok, Sigridur A Asgeirsdóttir, et al.

Pharmaceutical Research|January 10, 2008

Cell-specific delivery of a transforming growth factor-beta type I receptor kinase inhibitor to proximal tubular cells for the treatment of renal fibrosisJai Prakash, Martin H de Borst, Annemiek M van Loenen-Weemaes, et al.

Molecular Pharmacology|December 16, 2004

Optimized targeting of polyethylene glycol-stabilized anti-intercellular adhesion molecule 1 oligonucleotide/lipid particles to liver sinusoidal endothelial cellsMartin Bartsch, Alida H Weeke-Klimp, Henriëtte W M Morselt, et al.

Toxicological Sciences : an Official Journal of the Society of Toxicology|February 25, 2005

Precision-cut liver slices as a new model to study toxicity-induced hepatic stellate cell activation in a physiologic milieuMarja van de Bovenkamp, Geny M M Groothuis, Annelies L Draaisma, et al.

Pageof 6